IIMEC17 & OMF’s Directors In-Person Meeting

We are pleased to announce that Open Medicine Foundation (OMF) will attend the annual International ME Conference Week hosted by the UK charity Invest in ME Research.  

The international ME conference week events now span five days, and this year are arranged for 26 – 30 May 2025. This unique set of events now encapsulates a workshop for young/early career researchers, a research Colloquium, a public international conference, and meetings of the European ME Research Group.

On May 30, the IIMEC17 (the seventeenth international ME conference), titled Translating Research Into Diagnostics and Treatments, will take place. This event invites patient groups, patients, and carers to share their knowledge. To learn more and register, visit IIMEC17.

We are thrilled to share that all OMF’s CRC directors will be present, offering their unique perspectives and findings:

  • Jonas Bergquist, MD, PhD, Director of the ME/CFS Collaboration at Uppsala University
  • Ronald W. Davis, PhD, Director of the ME/CFS Collaborative Research Center at Stanford University
  • Christopher Armstrong, PhD, Director of the Melbourne ME/CFS Collaboration
  • Alain Moreau, PhD, Director of the ME/CFS Collaborative Research Center at the University of Montreal
  • David Systrom, MD, Co-Director of the ME/CFS Harvard Collaboration
  • Wenzhong Xiao, PhD, Co-Director of the ME/CFS Harvard Collaboration, Director of the Computational Research Center for Complex Diseases
  • Maureen Hanson, PhD, Scientific Advisory Board Member 

Our esteemed CEO and Founder, Linda Tannenbaum, will also be in attendance!

We would like to take this opportunity to thank Invest in ME for their continued dedication to bringing researchers together to drive meaningful progress in the fight against ME/CFS.

👉 Learn more about the conference!

👉 View the conference agenda! 

OMF’s Collaborative Research
Directors Annual In-Person Meeting

OMF’s Collaborative Research Center Directors from Harvard, Stanford, Montreal, Uppsala, and Melbourne hold monthly teleconferences to discuss research plans and share findings. However, our annual in-person meeting is a key moment for deeper collaboration.

This year, we will gather in Cambridge, UK, following the Invest in ME Research International ME Conference. Discussions will focus on research updates from OMF-funded projects, insights from our Computational Center’s network analysis, and major global discoveries. These conversations help refine our research priorities and identify promising targets for future clinical trials.

Enjoy these photos from our 2024 annual in-person meeting in Cambridge!

Collage of three photos from the 2024 annual directors' meeting, featuring Jonas Bergquist, Ron Davis, Christopher Armstrong, David Systrom, Wenzhong Xiao, Maureen Hanson, Linda Tannenbaum, and Danielle Meadows.


Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.


How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669